WEALTH EFFECTS LLC - PSYCHEMEDICS CORP ownership

PSYCHEMEDICS CORP's ticker is PMD and the CUSIP is 744375205. A total of 24 filers reported holding PSYCHEMEDICS CORP in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
WEALTH EFFECTS LLC ownership history of PSYCHEMEDICS CORP
ValueSharesWeighting
Q3 2023$161,582
-14.6%
40,701
-1.9%
0.08%
-3.6%
Q2 2023$189,243
-19.0%
41,501
-6.7%
0.08%
-30.8%
Q1 2023$233,629
+7.0%
44,5010.0%0.12%
-4.0%
Q4 2022$218,263
-24.0%
44,5010.0%0.12%
-29.0%
Q3 2022$287,0000.0%44,501
-1.8%
0.18%
+1.7%
Q2 2022$287,000
+4.0%
45,301
+13.2%
0.17%
+34.1%
Q1 2022$276,000
-5.2%
40,001
-3.5%
0.13%
+6.6%
Q4 2021$291,00041,4580.12%
Other shareholders
PSYCHEMEDICS CORP shareholders Q4 2022
NameSharesValueWeighting ↓
Tieton Capital Management, LLC 250,388$3,974,0004.46%
QUANTUM CAPITAL MANAGEMENT 63,246$1,004,0000.58%
Mill Road Capital Management LLC 14,896$236,0000.30%
Gs Investments, Inc. 15,800$250,746,0000.21%
RBF Capital, LLC 87,917$1,395,0000.18%
North Star Investment Management Corp. 85,282$1,353,0000.18%
CRAWFORD INVESTMENT COUNSEL INC 297,675$4,724,0000.16%
Uniplan Investment Counsel, Inc. 145,677$2,311,0000.16%
DEPRINCE RACE & ZOLLO INC 282,186$4,478,0000.13%
Moors & Cabot, Inc. 37,932$605,0000.10%
View complete list of PSYCHEMEDICS CORP shareholders